financetom
Business
financetom
/
Business
/
Incyte Gets FDA Approval for Opzelura in Children Aged 2 to 11
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Incyte Gets FDA Approval for Opzelura in Children Aged 2 to 11
Sep 20, 2025 9:29 PM

05:07 PM EDT, 09/18/2025 (MT Newswires) -- Incyte ( INCY ) said late Thursday the US Food and Drug Administration has approved the use of Opzelura cream to treat mild to moderate atopic dermatitis in non-immunocompromised children aged 2 to 11.

The milestone marks the third US approval for Opzelura, it said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US says MetLife unit reached settlement over Iran sanctions violations
US says MetLife unit reached settlement over Iran sanctions violations
Nov 15, 2024
WASHINGTON, Nov 14 (Reuters) - The U.S. Treasury Department said on Thursday that New York-based insurer MetLife's ( MET ) unit, American Life Insurance Co, agreed to settle its potential civil liability for over 2,300 apparent violations of sanctions against Iran. The Treasury's Office of Foreign Assets Control announced a $178,421 settlement with the MetLife ( MET ) unit. The...
Market Chatter: Ontario Signs $100 Million Deal With Elon Musk's Starlink System
Market Chatter: Ontario Signs $100 Million Deal With Elon Musk's Starlink System
Nov 15, 2024
03:56 PM EST, 11/14/2024 (MT Newswires) -- Premier Doug Ford's government has signed a $100-million deal with Elon Musk's SpaceX to deliver high-speed internet to remote residents in rural and northern Ontario, The Canadian Press is reporting Thursday. The new program called ONSAT -- which stands for Ontario Satellite -- will bring SpaceX's Starlink satellite internet system to 15,000 premises,...
Tyler Technologies Insider Sold Shares Worth $6,785,712, According to a Recent SEC Filing
Tyler Technologies Insider Sold Shares Worth $6,785,712, According to a Recent SEC Filing
Nov 15, 2024
03:56 PM EST, 11/14/2024 (MT Newswires) -- John S Marr Jr, Director, Executive Chair of the Board, on November 12, 2024, sold 11,000 shares in Tyler Technologies ( TYL ) for $6,785,712. Following the Form 4 filing with the SEC, Marr has control over a total of 58,371 shares of the company, with 6,983 shares held directly and 51,388 controlled...
BRIEF-Germany's Evotec Gets Takeover Interest From Halozyme At About 11 Euros Per Share - Bloomberg News
BRIEF-Germany's Evotec Gets Takeover Interest From Halozyme At About 11 Euros Per Share - Bloomberg News
Nov 15, 2024
Nov 14 (Reuters) - * GERMANY'S EVOTEC GETS TAKEOVER INTEREST FROM HALOZYME AT ABOUT €11 PER SHARE - BLOOMBERG NEWS Source text: https://tinyurl.com/2veteceh Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved